BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36

ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,450.60
0.52%
S&P ASX All Technology
3,929.60
0.37%
Brent Oil
72.27
-0.17%
US Dollar vs AUD
1.53659
-0.16%
Bitcoin
96,465.17
0.51%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Quantum Genomics (ALQGC) Share Price

Quantum Genomics

Quantum Genomics (ALQGC)

EU
0.0721
0.00
(0.00%)
Closed 28 November 3:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.0721
Bid
0.0068
Offer
0.0721
Volume
0.00
0.00 Day's Range 0.00
0.001 52 Week Range 0.1578
Market Cap
5.026M
Previous Close
0.0721
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,598,395
Shares Outstanding
69,709,954
Dividend Yield
-
PE Ratio
-1.54
Earnings Per Share (EPS)
-0.05
Revenue
36k
Net Profit
-3.17M

About Quantum Genomics

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
quantum-genomics.com/societe/
Headquarters
Paris, Paris, Fra
Founded
-
Quantum Genomics is listed in the Pharmaceutical Preparations sector of the Euronext with ticker ALQGC. The last closing price for Quantum Genomics was 0.07 €. Over the last year, Quantum Genomics shares have traded in a share price range of 0.001 € to 0.1578 €.

Quantum Genomics currently has 69,709,954 shares in issue. The market capitalisation of Quantum Genomics is 5.03 € million. Quantum Genomics has a price to earnings ratio (PE ratio) of -1.54.

Ask ADVFN Intelligence (AI)

ALQGC Latest News

More News

Quantum Genomics Announces Lack of Significant Efficacy for Firibastat in Their Phase III Study, FRESH and is Redirecting to New Developments

Firibastat efficacy non-significant versus placeboThe REFRESH study and the development of firibastat in cardiology have been stoppedCash of 11 million euros allotted to the development of new...

28 October 2022
GlobeNewswire Inc.

Bryan Garnier & Co Initiates the Coverage of Quantum Genomics with a Target Price at 13€ per Share

PARIS, Oct. 06, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

07 October 2022
GlobeNewswire Inc.

Quantum Genomics Publishes its 2022 First Half Results and Reviews its Activity

PARIS, Oct. 05, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

06 October 2022
GlobeNewswire Inc.

Quantum Genomics Announces That the Results Obtained with Firibastat in its Phase III Study, FRESH Will Now be Presented on November 7, 2022, During the AHA Conference in a Session Dedicated to Resistant Hypertension

PARIS, Sept. 26, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medications...

27 September 2022
GlobeNewswire Inc.

Quantum Genomics announces the appointment of its new Scientific Advisory Board

PARIS, June 27, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly...

28 June 2022
GlobeNewswire Inc.

Quantum Genomics Announces the End of Patient Recruitment for its Phase III Pivotal Study FRESH

PARIS, May 09, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth – FR0011648971 – ALQGC), a biopharmaceutical company specializing in the development of a new drug class directly...

10 May 2022
GlobeNewswire Inc.

Quantum Genomics Appoints Sarah Merlen Boulenger as Head of Regulatory Affairs

PARIS, May 04, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth : ALQGC, OTCQX : QNNTF), a biopharmaceutical company specializing in the development of a new drug class directly...

05 May 2022
GlobeNewswire Inc.

Quantum Genomics Publishes its Results for Fiscal Year 2021 and Provides a Corporate Update

PARIS, April 28, 2022 (GLOBE NEWSWIRE) -- Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development of a new class of medicinal...

29 April 2022
GlobeNewswire Inc.

Quantum Genomics Announces Successful Capital Raise with a Gross Sum of Approximately 15.6M€

Quantum Genomics has equipped itself with new financial means to pursue the development of firibastat and explore new therapeutic fields based on the patented technology platform built around...

27 April 2022
GlobeNewswire Inc.

Quantum Genomics Raises a Gross Amount of Approximately € 15 M

Launch of capital increase of approximately €15 million for institutional investors with cancellation of the pre-emptive subscription rightA minimum of €12 million subscription commitments...

27 April 2022
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.07210.07210.072100DE
4000.07210.07210.072100DE
120.021843.33996023860.05030.1380.00115983950.05044572DE
26-0.0573-44.28129829980.12940.1380.0017601010.05184021DE
52-0.0371-33.97435897440.10920.15780.0014372750.05847893DE
156-4.4659-98.41119435874.5384.5640.0013167470.49678692DE
260-3.0379-97.68167202573.116.1850.0013160021.87439455DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALNEVNeovacs
0.0002 €
(100.00%)
23.96M
ALEUPEuroplasma
0.0615 €
(97.75%)
12.45M
ALGAUGaussin
0.08 €
(90.48%)
3.38M
ATOAtos SE
1.013 €
(79.99%)
42.94M
ALTAILighton
16.79 €
(44.49%)
188.11k
BIDSGascogne DS
0.0006 €
(-72.73%)
197.99k
EMGDSEuromedis DS
0.0004 €
(-50.00%)
34.36k
MLMAZMazaro NV
2.16 €
(-28.00%)
500
MLIMLImalliance
0.33 €
(-23.26%)
9.9k
GNROGeNeuro SA
0.0562 €
(-14.85%)
116.8k
ATOAtos SE
1.013 €
(79.99%)
42.94M
BCPBanco Comercial Portugues SA
0.444 €
(-0.22%)
33.65M
ALNEVNeovacs
0.0002 €
(100.00%)
23.96M
ALDRVDrone Volt
0.0036 €
(2.86%)
23.3M
ALNRGEnergisme SA
0.0055 €
(-3.51%)
12.47M

Discussion

View Full Feed
Perk_Idaho Perk_Idaho 4 minutes ago
inveeeestor..... owned........again.
NWBO
skyrocketinsight skyrocketinsight 4 minutes ago
I think I did. You don't want to provide a link to your claims.
AXXA
Green doggie Green doggie 5 minutes ago
Quoted from a post on another board:

“Two potential positive catalysts outside of DR@V might kick start these Chinese stocks

First the new SEC Trump appointed chairman
Next a big one is in late 2025 Xi steps down.

Right now if you’ve been up on
EGOC
DjScottyT DjScottyT 6 minutes ago
So how would you all feel if this scumbag company did a reverse split? Would you still believe anything going forward? Lies have been told, money has been wasted. And now shareholders could possibly get screwed again. Unbelievable.
TSOI
DoF DoF 6 minutes ago
So Hop-on, Inc has funnelled $5,272, 852 into Digitalage, Inc, a company with a total authorised capital of $1,050,000.
Problem is, Digitalage, Inc is in default in its state of incorporation, Nevada, so it cannot conduct business.
A new company, Digitalage Media, Inc has been created
HPNN
jay_tee jay_tee 7 minutes ago
Exactly what's exciting when we really have no clue if anything positive will
Transpire for rnva common shareholders...?
RNVA
RKT989 RKT989 7 minutes ago
Either has Kosmos
ERHE
BDEZ BDEZ 7 minutes ago
Rogan O'Handley: I am once again confirming that just b/c we won this election doesn’t mean we fully trust the results

https://x.com/DC_Draino/status/1861814938169208963
real777mellon real777mellon 8 minutes ago
Excellent Ron! Thank you kindly for this info I'm gonna start reading right now!
LEHNQ
maperatpogi maperatpogi 8 minutes ago
Breakout Boards
Rank Board
1 Accredited Solutions Inc (ASII)
ASII
fuagf fuagf 9 minutes ago
LOL
Genz2 Genz2 9 minutes ago
Methinks, Happy Thanksgiving!! With Microsoft being investigated, the Biden administration might be doing some big things with our favorite little American company (Wave) as one of his last hurrahs! It seems like little old Wave that can do GREAT things could be set to go on stage with only known
jbsliverer jbsliverer 9 minutes ago
The kleptocrats have only just begun. Their party hasn't even started yet, just the early arrivals. Trump Jr does have a "wealth of experience". Getting to be an expert In tax evasion, corruption, snorting coke, a whole array of things. Not quite as good at the grift as his father, but he's c
BDEZ BDEZ 10 minutes ago
Seems like great news CT...
StayHumble StayHumble 10 minutes ago
100% Xpert BUYS and 69% Short 💹 Huzzah 💹$80💹

https://fintel.io/ss/us/dbmm#google_vignette

https://ih.advfn.com/stock-market/USOTC/digital-brand-media-and-pk-DBMM/trades?_gl=1*1phieb0*_gcl_au*MjA4OTI0MDQyNi4xNzMx
DBMM
Renee Renee 10 minutes ago
CMAX changed to CMAXQ, bankruptcy. Delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions
CMAX
ChannelTrader ChannelTrader 11 minutes ago
Excellent, good find, BDEZ !
Sheinbaum has agreed to stop all migration through Mexico that is heading towards the United States

https://x.com/TomHoman_/status/1861929459508789545
boston745 boston745 11 minutes ago
Alzheimer's May Not Actually Be a Brain Disease, an Expert Reveals

Alzheimer's as autoimmune disease

We believe that beta-amyloid is not an abnormally produced protein, but rather is a normally occurring molecule that is part of the brain's immune system. It is suppose
SINT
jdcpa1 jdcpa1 11 minutes ago
Sorry you are not owed anything. You ask alot of BS questions under an anonymous name. You are a no body to anyone online and surely to the company. Why would they give out all their trade secrets to you or anyone else? Your request is so ridiculous.. get a grip, your so called investigation is at a
SPZI
radly radly 11 minutes ago
Most likely, I Agree!
STEV
3331 3331 11 minutes ago
BIEL: Flagship product - RecoveryRX - now available to all veterans at all VA's!

Ted Fienning
BioElectronics Corporation
Harvard University
Marine Corp Pilot

"Share with any veteran you know using the VA: RecoveryRX is an FDA-approved pain managemen
BDEZ BDEZ 12 minutes ago
Microsoft’s gaming division is excluding whites from being hired to work on their video games

https://x.com/elonmusk/status/1861670383210111148

Your Recent History

EU
ALQGC
Quantum Genomics
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved

BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 60%* for ASX Level 1 & 2

1 year 40%, 2 years 40% and *3 years 60%

*Across 3 years $1958.40 only $783.36